All providers, regardless of where they work have a role in the shift to value-based care, but independent physicians need to have a voice in the transition, said Sibel Blau, MD, medical oncologist at Northwest Medical Specialties, PLLC.
All providers, regardless of where they work have a role in the shift to value-based care, but independent physicians need to have a voice in the transition, said Sibel Blau, MD, medical oncologist at Northwest Medical Specialties, PLLC.
Transcript
What role can independent physicians play in the transition to value-based care?
I think we all have challenges, whether we work in academic centers, or hospitals, or independent practices. I really believe though, as a private practice doctor, we have a chance to change the healthcare system. I think we can make a dent and start from there and grow this idea of going from fee-for-service to a value base.
I think independent physicians need to have a voice and pursue what is felt to be impossible. I think when we get together we know, we saw, what we can create together. We did little projects, we had fun doing it, we showed improvements in healthcare. Now we can grow and do it more globally and by bringing more practices together. I think that we will have a chance to do this without focusing on making millions of millions of dollars or flipping the organization into selling to something to make money.
The purpose is truly providing value-based care in our health system and helping the cost of this country’s huge expenditure in healthcare issues. And then providing the best care to our patients. I think we are able to do that, and I really believe we can get there.
Empowering Teams Begins With Human Connection: Missy Hopson, PhD
April 16th 2025Missy Hopson, PhD, Ochsner Health, discussed in detail the challenges of strengthening the patient-centered workforce, the power of community reputation for encouraging health care careers, and the influence of empowered workforces on patient outcomes.
Read More
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
Health Equity & Access Weekly Roundup: April 14, 2025
April 14th 2025From the potential impact of tariffs to the World Health Organization's year-long campaign launch focused on improving maternal and newborn health and addressing preventable deaths, here's the latest from the Center on Health Equity & Access.
Read More
National Data Show Rising Risk, Cost of CKD in Patients With Acute Myocardial Infarction
April 10th 2025A series of new studies from the National Kidney Foundation Spring Clinical Meeting exhibit the association between impaired kidney function and prolonged hospital stays, higher charges, and greater resource utilization.
Read More